Skip to content

Deferred taxes at other companies

Pfizer logo
PfizerPFE
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's deferred taxes?
Dogwood Therapeutics (DWTX) reported deferred taxes of $1.19K in Q1 2026.
How has Dogwood Therapeutics's deferred taxes changed year-over-year?
Dogwood Therapeutics's deferred taxes decreased by 99.4% year-over-year, from $190.54K to $1.19K.
What does deferred taxes mean?
This metric represents the non-cash tax expense or benefit resulting from temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. It reflects the future tax consequences of events that have been recognized in the financial statements but not yet in the tax return. Monitoring this helps investors understand the timing differences between accounting income and taxable income.